Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Fractyl Health Inc (GUTS)

Fractyl Health Inc (GUTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,084
  • Shares Outstanding, K 48,099
  • Annual Sales, $ 120 K
  • Annual Income, $ -77,090 K
  • EBIT $ -81 M
  • EBITDA $ -81 M
  • 60-Month Beta N/A
  • Price/Sales 813.67
  • Price/Cash Flow N/A
  • Price/Book 1.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.44
  • Number of Estimates 2
  • High Estimate -0.34
  • Low Estimate -0.53
  • Prior Year -8.02
  • Growth Rate Est. (year over year) +94.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.75 +21.71%
on 12/20/24
2.59 -17.76%
on 12/03/24
-0.46 (-17.76%)
since 12/02/24
3-Month
1.75 +21.71%
on 12/20/24
3.48 -38.81%
on 10/30/24
-0.19 (-8.19%)
since 10/02/24

Most Recent Stories

More News
Fractyl Health Reports Successful Delivery of RJVA-001 in Yucatan Pig Models, Paving the Way for First-in-Human Studies in 2025

RJVA-001 demonstrated effective pancreatic targeting and GLP-1 expression with no safety issues in Yucatan pigs, supporting human trials in 2025.Quiver AI SummaryFractyl Health, Inc. has successfully delivered...

GUTS : 2.13 (+3.40%)
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

GUTS : 2.13 (+3.40%)
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)

GUTS : 2.13 (+3.40%)
Fractyl Health to Participate in the Upcoming December Conferences

GUTS : 2.13 (+3.40%)
Why This Penny Stock Lost 13% Last Week While Markets Soared

Traders sold the news on this biotech stock's conference update.

GUTS : 2.13 (+3.40%)
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates

GUTS : 2.13 (+3.40%)
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024

GUTS : 2.13 (+3.40%)
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024

GUTS : 2.13 (+3.40%)
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024

GUTS : 2.13 (+3.40%)
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024

GUTS : 2.13 (+3.40%)

Business Summary

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA.

See More

Key Turning Points

3rd Resistance Point 2.40
2nd Resistance Point 2.33
1st Resistance Point 2.23
Last Price 2.13
1st Support Level 2.06
2nd Support Level 1.99
3rd Support Level 1.89

See More

52-Week High 14.50
Fibonacci 61.8% 9.63
Fibonacci 50% 8.12
Fibonacci 38.2% 6.61
Last Price 2.13
52-Week Low 1.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar